Paris and Stockholm Push Back: EU Drug Shortage Plan Faces Tough Talks

French and Swedish lawmakers have expressed strong concerns about the European Union’s new plan to solve medicine shortages. The plan, called the Critical Medicines Act, aims to ensure that people across Europe have better access to important medicines. However, France and Sweden are not fully happy with some parts of the proposal. Although they did not formally block the plan with a “yellow card” challenge, their objections indicate that negotiations in the EU Council could be difficult.

The Critical Medicines Act is designed to prevent drug shortages by improving supply chains and increasing cooperation between member states. The European Commission hopes this law will make medicines more available, especially for critical treatments. Yet, the concerns raised by France and Sweden highlight possible issues in how the law would work in practice. These lawmakers worry about the impact on national decision-making and healthcare systems.

As discussions continue, Brussels officials must address these key objections to move forward. The outcome will be important for all EU countries, especially as medicine shortages remain a serious problem. The next steps in Council negotiations will show if the plan can win wider support.

Stay tuned for Questiqa Europe News for more latest updates.

About The Author